Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9Y6Y9 (LY96_HUMAN)

Last modified February 9, 2010. Version 84. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Lymphocyte antigen 96
      Short name=Ly-96
Alternative name(s):
    Protein MD-2
    ESOP-1
Gene names
Name: LY96
Synonyms: ESOP1, MD2
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length160 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram-positive and Gram-negative bacteria. Enhances TLR4-dependent activation of NF-kappa-B. Cells expressing both MD2 and TLR4, but not TLR4 alone, respond to LPS.

Subunit structure

Heterogeneous homopolymer formed from homodimers; disulfide-linked. Belongs to the lipopolysaccharide (LPS) receptor, a multi-protein complex containing at least CD14, LY96 and TLR4. Binds to the extracellular domains of TLR2 and TLR4. Ligand binding induces interaction with TLR4 and oligomerization of the complex. Ref.6 Ref.7 Ref.8 Ref.10

Subcellular location

Secretedextracellular space.

Post-translational modification

N-glycosylated; high-mannose. Ref.7 Ref.10

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 1818 Potential
Chain19 – 160142Lymphocyte antigen 96
PRO_0000018619

Regions

Region119 – 1235Interaction with lipopolysaccharide

Amino acid modifications

Glycosylation261N-linked (GlcNAc...) Ref.10
Glycosylation1141N-linked (GlcNAc...) Ref.10
Disulfide bond25 ↔ 51 Ref.7 Ref.8 Ref.10
Disulfide bond37 ↔ 148 Ref.7 Ref.8 Ref.10
Disulfide bond95 ↔ 105 Ref.7 Ref.8 Ref.10

Natural variations

Natural variant561G → R: dbSNP rs6472812.
VAR_050030
Natural variant1571P → S: dbSNP rs11466004.
VAR_024532

Experimental info

Mutagenesis951C → Y: Abolishes LPS-response. Ref.3

Secondary structure

....................... 160
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Q9Y6Y9-1 [UniParc].

Last modified November 1, 1999. Version 1.
Checksum: 1E83AFF583636D7A

FASTA16018,446
        10         20         30         40         50         60 
MLPFLFFSTL FSSIFTEAQK QYWVCNSSDA SISYTYCDKM QYPISINVNP CIELKGSKGL 

        70         80         90        100        110        120 
LHIFYIPRRD LKQLYFNLYI TVNTMNLPKR KEVICRGSDD DYSFCRALKG ETVNTTISFS 

       130        140        150        160 
FKGIKFSKGK YKCVVEAISG SPEEMLFCLE FVILHQPNSN 

« Hide

References

« Hide 'large scale' references
[1]"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4."
Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M.
J. Exp. Med. 189:1777-1782(1999) [PubMed: 10359581] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Uterus.
[2]"ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice."
Kato K., Morrison A.M., Nakano T., Tashiro K., Honjo T.
Blood 96:362-364(2000) [PubMed: 10891475] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[3]"Molecular genetic analysis of an endotoxin nonresponder mutant cell line. A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling."
Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A., Heine H., Latz E., Monks B.G., Schwartz D.A., Miyake K., Golenbock D.T.
J. Exp. Med. 194:79-88(2001) [PubMed: 11435474] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF CYS-95.
[4]"Natural selection in the TLR-related genes in the course of primate evolution."
Nakajima T., Ohtani H., Satta Y., Uno Y., Akari H., Ishida T., Kimura A.
Immunogenetics 60:727-735(2008) [PubMed: 18810425] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Liver.
[6]"MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components."
Dziarski R., Wang Q., Miyake K., Kirschning C.J., Gupta D.
J. Immunol. 166:1938-1944(2001) [PubMed: 11160242] [Abstract]
Cited for: INTERACTION WITH TLR2 AND TLR4.
[7]"Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4."
Visintin A., Mazzoni A., Spitzer J.A., Segal D.M.
Proc. Natl. Acad. Sci. U.S.A. 98:12156-12161(2001) [PubMed: 11593030] [Abstract]
Cited for: DISULFIDE BONDS, GLYCOSYLATION.
[8]"The role of disulfide bonds in the assembly and function of MD-2."
Mullen G.E.D., Kennedy M.N., Visintin A., Mazzoni A., Leifer C.A., Davies D.R., Segal D.M.
Proc. Natl. Acad. Sci. U.S.A. 100:3919-3924(2003) [PubMed: 12642668] [Abstract]
Cited for: INTERCHAIN DISULFIDE BOND.
[9]"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran."
Kim H.M., Park B.S., Kim J.-I., Kim S.E., Lee J., Oh S.C., Enkhbayar P., Matsushima N., Lee H., Yoo O.J., Lee J.-O.
Cell 130:906-917(2007) [PubMed: 17803912] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 19-158 IN COMPLEX WITH TLR4 AND LIPOPOLYSACCHARIDE ANALOG.
[10]"Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa."
Ohto U., Fukase K., Miyake K., Satow Y.
Science 316:1632-1634(2007) [PubMed: 17569869] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 17-160 IN COMPLEX WITH LIPID IV-A, DISULFIDE BONDS, GLYCOSYLATION AT ASN-26 AND ASN-114.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AB018549 mRNA. Translation: BAA78717.1.
AF168121 mRNA. Translation: AAF89635.1.
AB446498 mRNA. Translation: BAG55275.1.
BC020690 mRNA. Translation: AAH20690.1.
IPIIPI00022250.
RefSeqNP_056179.2.
UniGeneHs.660766

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1T2Zmodel-A19-160[»]
2E56X-ray2.00A17-160[»]
2E59X-ray2.21A17-160[»]
2Z65X-ray2.70C/D19-158[»]
3FXIX-ray3.10C/D19-160[»]
ModBaseSearch...

Protein-protein interaction databases

STRINGQ9Y6Y9.

Proteomic databases

PRIDEQ9Y6Y9.

Genome annotation databases

EnsemblENST00000284818; ENSP00000284818; ENSG00000154589; Homo sapiens. [Genome view]
GeneID23643.
KEGGhsa:23643.
UCSCuc003yad.1. human.

Organism-specific databases

CTD23643.
GeneCardsGC08P075066.
H-InvDBHIX0007590.
HGNCHGNC:17156. LY96.
MIM605243. gene.
PharmGKBPA134924906.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG20247.
HOGENOMHBG125893.
HOVERGENQ9Y6Y9.
InParanoidQ9Y6Y9.

Enzyme and pathway databases

ReactomeREACT_6900. Signaling in Immune system.
REACT_6968. Mal Cascade.

Gene expression databases

ArrayExpressQ9Y6Y9.
BgeeQ9Y6Y9.
CleanExHS_LY96.
GenevestigatorQ9Y6Y9.
GermOnlineENSG00000154589. Homo sapiens.

Family and domain databases

InterProIPR003172. MD-2_lipid-recog.
[Graphical view]
PfamPF02221. E1_DerP2_DerF2. 1 hit.
[Graphical view]
SMARTSM00737. ML. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio46449.
SOURCESearch...

Entry information

Entry nameLY96_HUMAN
AccessionPrimary (citable) accession number: Q9Y6Y9
Secondary accession number(s): B3Y6A5
Entry history
Integrated into UniProtKB/Swiss-Prot: March 27, 2002
Last sequence update: November 1, 1999
Last modified: February 9, 2010
This is version 84 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 8

Human chromosome 8: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents